Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara La Ferla

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Oncogene|April 3, 2020
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulationFrancesca Ricciardiello, Yang Gang, Roberta Palorini, et al.
Cell Death & Disease|March 9, 2018
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosisFrancesca Ricciardiello, Giuseppina Votta, Roberta Palorini, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 20, 2016
(18)F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's diseaseJohanna Rokka, Anniina Snellman, Martti Kaasalainen, et al.
Nanomedicine (London, England)|September 11, 2020
Cellulose nanocrystals: a multimodal tool to enhance the targeted drug delivery against bone disordersLuca Zoia, Annalisa Morelli, Laura Talamini, et al.
ACS Nano|June 26, 2012
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's diseaseBenjamin Le Droumaguet, Julien Nicolas, Davide Brambilla, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Oncogene|April 3, 2020
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulationFrancesca Ricciardiello, Yang Gang, Roberta Palorini, et al.
Cell Death & Disease|March 9, 2018
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosisFrancesca Ricciardiello, Giuseppina Votta, Roberta Palorini, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 20, 2016
(18)F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's diseaseJohanna Rokka, Anniina Snellman, Martti Kaasalainen, et al.
Nanomedicine (London, England)|September 11, 2020
Cellulose nanocrystals: a multimodal tool to enhance the targeted drug delivery against bone disordersLuca Zoia, Annalisa Morelli, Laura Talamini, et al.
ACS Nano|June 26, 2012
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's diseaseBenjamin Le Droumaguet, Julien Nicolas, Davide Brambilla, et al.
Pageof 5